Evaluates the oxidation reactivity of a nonheme iron complex with mixed N/S ligands, indicating potential for catalytic applications.
Mononuclear nonheme iron(IV)–oxo species supported by mixed nitrogen–sulfur (N/S) ligands remain scarce, despite the prevalence of sulfur donors in biological iron sites and their expected impact on ferryl reactivity and catalyst design. In this work, a seven-coordinate iron(II) complex, [(N3S2)FeII(ClO4)2], bearing a rigid 15-membered N3S2 macrocycle, is shown to rapidly generate a mononuclear nonheme FeIV=O intermediate upon reaction with m-chloroperbenzoic (m-CPBA) acid in acetonitrile. The FeIV=O species forms within ≤2 s and is thermally persistent (t1/2 = 4.3 h at 25 °C), albeit in partial yield (~39% FeIV=O by Mössbauer spectroscopy), placing it in an intermediate regime between highly reactive but short-lived ferryl species and more inert, long-lived analogues. The intermediate is characterized by Mössbauer spectroscopy (δ = 0.35 mm s−1, ΔEQ = 0.90 mm s−1, ΓFWHM = 0.30 mm s−1, relative area = 39.4%), EPR silence, a UV–vis absorption band at 428 nm, and cryogenic high-resolution ESI–MS (m/z 223.510, (N3S2)FeIV=O2+). Stopped-flow kinetic studies reveal saturation behavior that is well described by a pre-equilibrium oxidant-association model and subsequent O–O bond activation, with apparent activation parameters of ΔH‡ = 17.7 kJ mol−1 and ΔS‡ = −155 J mol−1 K−1, indicating a highly ordered transition state within the seven-coordinate N3S2 framework under the conditions employed. Functionally, the FeIV=O species mediates clean oxygen-atom transfer to triphenylphosphine (k2 = 8.1 × 10−2 M−1 s−1) with an effective turnover number of ~12 after correction for the FeIV=O yield, establishing that this mixed N/S platform is catalytically competent under mild conditions, though less reactive than state-of-the-art all-nitrogen systems. Collectively, these findings identify the seven-coordinate N3S2 macrocycle as a mixed-donor platform that moderately extends ferryl lifetime while retaining measurable oxo-transfer reactivity, providing mechanistic guidance for the development of nonheme iron oxidation catalysts that incorporate sulfur donors.
No takes yet. Share an insight, caveat, or question.
Mansour et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: